| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2003;42:1206.)
© 2003 American Heart Association, Inc.
JNC 7: Complete Report |
From Boston University School of Medicine (A.V.C.), Boston, Mass; Rush University Medical Center (G.L.B., H.R.B.), Chicago, Ill; Veterans Affairs Medical Center (W.C.C.), Memphis, Tenn; University of Michigan (L.A.G.), Ann Arbor, Mich; State University of New York at Buffalo School of Medicine (J.L.I. Jr.), Buffalo, NY; University of Mississippi Medical Center (D.W.J.), Jackson, Miss; University of Miami (B.J.M.), Miami, Fla; University of Alabama at Birmingham (S.O.), Birmingham, Ala; Case Western Reserve University (J.T.W. Jr.), Cleveland, Ohio; National Heart, Lung, and Blood Institute (E.J.R.), Bethesda, Md.
Correspondence to Edward J. Roccella, PhD, Coordinator, National High Blood Pressure Education Program, National Heart, Lung, and Blood Institute, National Institutes of Health, Building 31, Room 4A10, 31 Center Drive MSC 2480, Bethesda, MD 20892. E-mail roccelle{at}nhlbi.nih.gov
The National High Blood Pressure Education Program presents the complete Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Like its predecessors, the purpose is to provide an evidence-based approach to the prevention and management of hypertension. The key messages of this report are these: in those older than age 50, systolic blood pressure (BP) of greater than 140 mm Hg is a more important cardiovascular disease (CVD) risk factor than diastolic BP; beginning at 115/75 mm Hg, CVD risk doubles for each increment of 20/10 mm Hg; those who are normotensive at 55 years of age will have a 90% lifetime risk of developing hypertension; prehypertensive individuals (systolic BP 120139 mm Hg or diastolic BP 8089 mm Hg) require health-promoting lifestyle modifications to prevent the progressive rise in blood pressure and CVD; for uncomplicated hypertension, thiazide diuretic should be used in drug treatment for most, either alone or combined with drugs from other classes; this report delineates specific high-risk conditions that are compelling indications for the use of other antihypertensive drug classes (angiotensin-converting enzyme inhibitors, angiotensin-receptor blockers, beta-blockers, calcium channel blockers); two or more antihypertensive medications will be required to achieve goal BP (<140/90 mm Hg, or <130/80 mm Hg) for patients with diabetes and chronic kidney disease; for patients whose BP is more than 20 mm Hg above the systolic BP goal or more than 10 mm Hg above the diastolic BP goal, initiation of therapy using two agents, one of which usually will be a thiazide diuretic, should be considered; regardless of therapy or care, hypertension will be controlled only if patients are motivated to stay on their treatment plan. Positive experiences, trust in the clinician, and empathy improve patient motivation and satisfaction. This report serves as a guide, and the committee continues to recognize that the responsible physicians judgment remains paramount.
This article has been cited by other articles:
![]() |
A. K. Mottl, S. Vupputuri, S. A. Cole, L. Almasy, H. H.H. Goring, V. P. Diego, S. Laston, N. Shara, E. T. Lee, L. G. Best, et al. Linkage Analysis of Albuminuria J. Am. Soc. Nephrol., July 1, 2009; 20(7): 1597 - 1606. [Abstract] [Full Text] [PDF] |
||||
![]() |
P Hedberg, J Ohrvik, I Lonnberg, and G Nilsson Augmented blood pressure response to exercise is associated with improved long-term survival in older people Heart, July 1, 2009; 95(13): 1072 - 1078. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Caton, E. M. Bell, C. M. Druschel, M. M. Werler, A. E. Lin, M. L. Browne, L.-A. McNutt, P. A. Romitti, A. A. Mitchell, R. S. Olney, et al. Antihypertensive Medication Use During Pregnancy and the Risk of Cardiovascular Malformations Hypertension, July 1, 2009; 54(1): 63 - 70. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Barton and M. R. Meyer Postmenopausal Hypertension: Mechanisms and Therapy Hypertension, July 1, 2009; 54(1): 11 - 18. [Full Text] [PDF] |
||||
![]() |
L. C. Plantinga, E. R. Miller III, L. A. Stevens, R. Saran, K. Messer, N. Flowers, L. Geiss, N. R. Powe, and for the Centers for Disease Control and Prevention Blood Pressure Control Among Persons Without and With Chronic Kidney Disease: US Trends and Risk Factors 1999-2006 Hypertension, July 1, 2009; 54(1): 47 - 56. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Calhoun, Y. Lacourciere, Y. T. Chiang, and R. D. Glazer Triple Antihypertensive Therapy With Amlodipine, Valsartan, and Hydrochlorothiazide: A Randomized Clinical Trial Hypertension, July 1, 2009; 54(1): 32 - 39. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Ritz The Kidney: Both Culprit and Victim Hypertension, July 1, 2009; 54(1): 25 - 26. [Full Text] [PDF] |
||||
![]() |
C. Rheaume, B. J. Arsenault, S. Belanger, L. Perusse, A. Tremblay, C. Bouchard, P. Poirier, and J.-P. Despres Low Cardiorespiratory Fitness Levels and Elevated Blood Pressure: What Is the Contribution of Visceral Adiposity? Hypertension, July 1, 2009; 54(1): 91 - 97. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. R. Black Triple Fixed-Dose Combination Therapy: Back to the Past Hypertension, July 1, 2009; 54(1): 19 - 22. [Full Text] [PDF] |
||||
![]() |
T. H. Marwick, M. D. Hordern, T. Miller, D. A. Chyun, A. G. Bertoni, R. S. Blumenthal, G. Philippides, A. Rocchini, and on behalf of the American Heart Association Exerci Exercise Training for Type 2 Diabetes Mellitus: Impact on Cardiovascular Risk: A Scientific Statement From the American Heart Association Circulation, June 30, 2009; 119(25): 3244 - 3262. [Full Text] [PDF] |
||||
![]() |
D. S. Lee, P. Gona, R. S. Vasan, M. G. Larson, E. J. Benjamin, T. J. Wang, J. V. Tu, and D. Levy Relation of Disease Pathogenesis and Risk Factors to Heart Failure With Preserved or Reduced Ejection Fraction: Insights From the Framingham Heart Study of the National Heart, Lung, and Blood Institute Circulation, June 23, 2009; 119(24): 3070 - 3077. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. T.H. Yeh and C. L. Bickford Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management. J. Am. Coll. Cardiol., June 16, 2009; 53(24): 2231 - 2247. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. T. O'Connor, B. Caffo, A. B. Newman, S. F. Quan, D. M. Rapoport, S. Redline, H. E. Resnick, J. Samet, and E. Shahar Prospective Study of Sleep-disordered Breathing and Hypertension: The Sleep Heart Health Study Am. J. Respir. Crit. Care Med., June 15, 2009; 179(12): 1159 - 1164. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S Sever, A. H Gradman, and M. Azizi Managing cardiovascular and renal risk: the potential of direct renin inhibition Journal of Renin-Angiotensin-Aldosterone System, June 1, 2009; 10(2): 65 - 76. [Abstract] [PDF] |
||||
![]() |
S. S. Shord, L. R. Bressler, L. A. Tierney, S. Cuellar, and A. George Understanding and managing the possible adverse effects associated with bevacizumab Am. J. Health Syst. Pharm., June 1, 2009; 66(11): 999 - 1013. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Elijovich and C. Laffer A role for single-pill triple therapy in hypertension Therapeutic Advances in Cardiovascular Disease, June 1, 2009; 3(3): 231 - 240. [Abstract] [PDF] |
||||
![]() |
M. B. Lodish, N. Sinaii, N. Patronas, D. L. Batista, M. Keil, J. Samuel, J. Moran, S. Verma, J. Popovic, and C. A. Stratakis Blood Pressure in Pediatric Patients with Cushing Syndrome J. Clin. Endocrinol. Metab., June 1, 2009; 94(6): 2002 - 2008. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Faria, R. S. Moraes, D. C. Sobral-Filho, A. G. Rego, M. F.P. Baracho, E. S.T. Egito, and J. Brandao-Neto Autonomic modulation in patients with congenital generalized lipodystrophy (Berardinelli-Seip syndrome) Europace, June 1, 2009; 11(6): 763 - 769. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ceroni, L. J. Chaar, R. L. Bombein, and L. C. Michelini Chronic absence of baroreceptor inputs prevents training-induced cardiovascular adjustments in normotensive and spontaneously hypertensive rats Exp Physiol, June 1, 2009; 94(6): 630 - 640. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Etgen, D. Sander, M. Chonchol, C. Briesenick, H. Poppert, H. Forstl, and H. Bickel Chronic kidney disease is associated with incident cognitive impairment in the elderly: the INVADE study Nephrol. Dial. Transplant., May 29, 2009; (2009) gfp230v2. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Ritz and A. Tomaschitz Aldosterone, a vasculotoxic agent--novel functions for an old hormone Nephrol. Dial. Transplant., May 27, 2009; (2009) gfp206v1. [Full Text] [PDF] |
||||
![]() |
R. Mogelvang, P. Sogaard, S. A. Pedersen, N. T. Olsen, J. L. Marott, P. Schnohr, J. P. Goetze, and J. S. Jensen Cardiac Dysfunction Assessed by Echocardiographic Tissue Doppler Imaging Is an Independent Predictor of Mortality in the General Population Circulation, May 26, 2009; 119(20): 2679 - 2685. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. G. Allison Improving Weight Loss in Cardiac Rehabilitation Circulation, May 26, 2009; 119(20): 2650 - 2652. [Full Text] [PDF] |
||||
![]() |
P. A. Sarafidis and G. L. Bakris Does Evidence Support Renin-Angiotensin System Blockade for Slowing Nephropathy Progression in Elderly Persons? Ann Intern Med, May 19, 2009; 150(10): 731 - 733. [Full Text] [PDF] |
||||
![]() |
L. B. Hoffman, J. Schmeidler, G. T. Lesser, M. S. Beeri, D. P. Purohit, H. T. Grossman, and V. Haroutunian Less Alzheimer disease neuropathology in medicated hypertensive than nonhypertensive persons Neurology, May 19, 2009; 72(20): 1720 - 1726. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Lopes, J. L. Bragg-Gresham, S. P. B. Ramirez, V. E. Andreucci, T. Akiba, A. Saito, S. H. Jacobson, B. M. Robinson, F. K. Port, N. A. Mason, et al. Prescription of antihypertensive agents to haemodialysis patients: time trends and associations with patient characteristics, country and survival in the DOPPS Nephrol. Dial. Transplant., May 14, 2009; (2009) gfp212v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. S. Muxfeldt, C. R. L. Cardoso, and G. F. Salles Prognostic Value of Nocturnal Blood Pressure Reduction in Resistant Hypertension Arch Intern Med, May 11, 2009; 169(9): 874 - 880. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Terentes-Printzios, C. Vlachopoulos, C. Stefanadis, S. K. Dudeja, R. K. Dudeja, J. S. Williams, S. Brown, and P. R. Conlin Blood-Pressure Measurement N. Engl. J. Med., May 7, 2009; 360(19): 2034 - 2035. [Full Text] [PDF] |
||||
![]() |
D. L. Howard, A. P. Carson, D. N. Holmes, and J. S. Kaufman Consistency of Care and Blood Pressure Control among Elderly African Americans and Whites with Hypertension J Am Board Fam Med, May 1, 2009; 22(3): 307 - 315. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. T. Einhorn National Heart, Lung, and Blood Institute-Initiated Program "Interventions to Improve Hypertension Control Rates in African Americans": Background and Implementation Circ Cardiovasc Qual Outcomes, May 1, 2009; 2(3): 236 - 240. [Full Text] [PDF] |
||||
![]() |
G. Ogedegbe, J. N. Tobin, S. Fernandez, W. Gerin, M. Diaz-Gloster, A. Cassells, C. Khalida, T. Pickering, A. Schoenthaler, and J. Ravenell Counseling African Americans to Control Hypertension (CAATCH) Trial: A Multi-Level Intervention to Improve Blood Pressure Control in Hypertensive Blacks Circ Cardiovasc Qual Outcomes, May 1, 2009; 2(3): 249 - 256. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. W. Rhee, J. R. Stimers, W. Wang, and L. Pang Vascular Smooth Muscle-Specific Knockdown of the Noncardiac Form of the L-Type Calcium Channel by MicroRNA-Based Short Hairpin RNA as a Potential Antihypertensive Therapy J. Pharmacol. Exp. Ther., May 1, 2009; 329(2): 775 - 782. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Izzedine, S. Ederhy, F. Goldwasser, J. C. Soria, G. Milano, A. Cohen, D. Khayat, and J. P. Spano Management of hypertension in angiogenesis inhibitor-treated patients Ann. Onc., May 1, 2009; 20(5): 807 - 815. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Lewis, K. M. Fox, M. F. Bullano, S. Grandy, and for the SHIELD Study Group Knowledge of Heart Disease Risk Among SHIELD Respondents With Dyslipidemia Circ Cardiovasc Qual Outcomes, May 1, 2009; 2(3): 207 - 212. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. C. Lavallee, J. Labreuche, F. Gongora-Rivera, A. Jaramillo, D. Brenner, I. F Klein, P.-J. Touboul, E. Vicaut, P. Amarenco, and on behalf of the Lacunar-B.I.C.H.A.T. Investigator Placebo-Controlled Trial of High-Dose Atorvastatin in Patients With Severe Cerebral Small Vessel Disease Stroke, May 1, 2009; 40(5): 1721 - 1728. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Hunt, W. T. Abraham, M. H. Chin, A. M. Feldman, G. S. Francis, T. G. Ganiats, M. Jessup, M. A. Konstam, D. M. Mancini, K. Michl, et al. 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation J. Am. Coll. Cardiol., April 14, 2009; 53(15): e1 - e90. [Full Text] [PDF] |
||||
![]() |
2005 WRITING COMMITTEE MEMBERS, S. A. Hunt, W. T. Abraham, M. H. Chin, A. M. Feldman, G. S. Francis, T. G. Ganiats, M. Jessup, M. A. Konstam, D. M. Mancini, et al. 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transplantation Circulation, April 14, 2009; 119(14): e391 - e479. [Full Text] [PDF] |
||||
![]() |
A. V. Tess and G. W. Smetana Medical Evaluation of Patients Undergoing Electroconvulsive Therapy N. Engl. J. Med., April 2, 2009; 360(14): 1437 - 1444. [Full Text] [PDF] |
||||
![]() |
M. Sereg, A. Szappanos, J. Toke, K. Karlinger, K. Feldman, E. Kaszper, I. Varga, E. Glaz, K. Racz, and M. Toth Atherosclerotic risk factors and complications in patients with non-functioning adrenal adenomas treated with or without adrenalectomy: a long-term follow-up study Eur. J. Endocrinol., April 1, 2009; 160(4): 647 - 655. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. E. de Galan, V. Perkovic, T. Ninomiya, A. Pillai, A. Patel, A. Cass, B. Neal, N. Poulter, S. Harrap, C.-E. Mogensen, et al. Lowering Blood Pressure Reduces Renal Events in Type 2 Diabetes J. Am. Soc. Nephrol., April 1, 2009; 20(4): 883 - 892. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Muntner, M. Krousel-Wood, A. D. Hyre, E. Stanley, W. C. Cushman, J. A. Cutler, L. B. Piller, G. A. Goforth, and P. K. Whelton Antihypertensive Prescriptions for Newly Treated Patients Before and After the Main Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Results and Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Guidelines Hypertension, April 1, 2009; 53(4): 617 - 623. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Feldman and F. A. McAlister Postgame Wrap of the Ultimate Blood Pressure Megatrial: Did It Score an ALLHAT Trick or Was It "Three Strikes and You're Out?" Hypertension, April 1, 2009; 53(4): 595 - 597. [Full Text] [PDF] |
||||
![]() |
P. C. Schulze Beneficial Effects of Moderate Exercise in Arterial Hypertension Hypertension, April 1, 2009; 53(4): 600 - 601. [Full Text] [PDF] |
||||
![]() |
J. M. Tobis and A. Perlowski Atheroma volume by intravascular ultrasound as a surrogate for clinical end points. J. Am. Coll. Cardiol., March 31, 2009; 53(13): 1116 - 1118. [Full Text] [PDF] |
||||
![]() |
CORONARY REVASCULARIZATION WRITING GROUP, M. R. Patel, G. J. Dehmer, J. W. Hirshfeld, P. K. Smith, and J. A. Spertus ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization: A Report of the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology: Endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography Circulation, March 10, 2009; 119(9): 1330 - 1352. [Full Text] [PDF] |
||||
![]() |
S. S. Gidding, A. H. Lichtenstein, M. S. Faith, A. Karpyn, J. A. Mennella, B. Popkin, J. Rowe, L. Van Horn, and L. Whitsel Implementing American Heart Association Pediatric and Adult Nutrition Guidelines: A Scientific Statement From the American Heart Association Nutrition Committee of the Council on Nutrition, Physical Activity and Metabolism, Council on Cardiovascular Disease in the Young, Council on Arteriosclerosis, Thrombosis and Vascular Biology, Council on Cardiovascular Nursing, Council on Epidemiology and Prevention, and Council for High Blood Pressure Research Circulation, March 3, 2009; 119(8): 1161 - 1175. [Full Text] [PDF] |
||||
![]() |
R. Mogelvang, P. Sogaard, S. A. Pedersen, N. T. Olsen, P. Schnohr, and J. S. Jensen Tissue Doppler echocardiography in persons with hypertension, diabetes, or ischaemic heart disease: the Copenhagen City Heart Study Eur. Heart J., March 2, 2009; 30(6): 731 - 739. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kalaitzidis and G. Bakris Should nephrologists use beta-blockers? A perspective Nephrol. Dial. Transplant., March 1, 2009; 24(3): 701 - 702. [Full Text] [PDF] |
||||
![]() |
M.A.C. Onuigbo Reno-prevention vs. reno-protection: a critical re-appraisal of the evidence-base from the large RAAS blockade trials after ontarget--a call for more circumspection QJM, March 1, 2009; 102(3): 155 - 167. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R. Wenzel, T. Littke, S. Kuranoff, C. Jurgens, H. Bruck, E. Ritz, T. Philipp, A. Mitchell, and for the SPP301 (Avosentan) Endothelin Antagonist E Avosentan Reduces Albumin Excretion in Diabetics with Macroalbuminuria J. Am. Soc. Nephrol., March 1, 2009; 20(3): 655 - 664. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M Trompeter and D. E Havrda Impact of Obtaining Medications from Pharmaceutical Company Assistance Programs on Therapeutic Goals Ann. Pharmacother., March 1, 2009; 43(3): 469 - 477. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Chiolero, F. Paccaud, and P. Bovet Upward Hypertension Trends: Changes in Blood Pressure or in Antihypertensive Treatment? Hypertension, March 1, 2009; 53(3): e22 - e22. [Full Text] [PDF] |
||||
![]() |
P. Kokkinos, A. Manolis, A. Pittaras, M. Doumas, A. Giannelou, D. B. Panagiotakos, C. Faselis, P. Narayan, S. Singh, and J. Myers Exercise Capacity and Mortality in Hypertensive Men With and Without Additional Risk Factors Hypertension, March 1, 2009; 53(3): 494 - 499. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Patel, G. J. Dehmer, J. W. Hirshfeld, P. K. Smith, and J. A. Spertus ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization: A Report by the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology Endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography J. Am. Coll. Cardiol., February 10, 2009; 53(6): 530 - 553. [Full Text] [PDF] |
||||
![]() |
Y. W. Endeshaw, W. B. White, M. Kutner, J. G. Ouslander, and D. L. Bliwise Sleep-Disordered Breathing and 24-Hour Blood Pressure Pattern Among Older Adults J Gerontol A Biol Sci Med Sci, February 5, 2009; (2009) gln011v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Crimmins, J. K. Kim, and T. E. Seeman Poverty and Biological Risk: The Earlier "Aging" of the Poor J Gerontol A Biol Sci Med Sci, February 4, 2009; (2009) gln010v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Cooper-DeHoff, M. A. Pacanowski, and C. J. Pepine Cardiovascular therapies and associated glucose homeostasis: implications across the dysglycemia continuum. J. Am. Coll. Cardiol., February 3, 2009; 53(5 Suppl): S28 - S34. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Dunn, B. Bleske, M. Dorsch, T. Macaulay, B. Van Tassell, and O. Vardeny Nutrition and Heart Failure: Impact of Drug Therapies and Management Strategies Nutr Clin Pract, February 1, 2009; 24(1): 60 - 75. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Bruandet, F Richard, S Bombois, C A Maurage, V Deramecourt, F Lebert, P Amouyel, and F Pasquier Alzheimer disease with cerebrovascular disease and vascular dementia: clinical features and course compared with Alzheimer disease J. Neurol. Neurosurg. Psychiatry, February 1, 2009; 80(2): 133 - 139. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. N. Borrell Race, Ethnicity, and Self-Reported Hypertension: Analysis of Data From the National Health Interview Survey, 1997-2005 Am J Public Health, February 1, 2009; 99(2): 313 - 319. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. NIKPOUR, D. D. GLADMAN, D. IBANEZ, I. N. BRUCE, R. J. BURNS, and M. B. UROWITZ Myocardial Perfusion Imaging in Assessing Risk of Coronary Events in Patients with Systemic Lupus Erythematosus J Rheumatol, February 1, 2009; 36(2): 288 - 294. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. McDonald, R. P. Hertz, A. N. Unger, and M. B. Lustik Prevalence, Awareness, and Management of Hypertension, Dyslipidemia, and Diabetes Among United States Adults Aged 65 and Older J Gerontol A Biol Sci Med Sci, February 1, 2009; 64A(2): 256 - 263. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Nehra Erectile Dysfunction and Cardiovascular Disease: Efficacy and Safety of Phosphodiesterase Type 5 Inhibitors in Men With Both Conditions Mayo Clin. Proc., February 1, 2009; 84(2): 139 - 148. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Poon, L. S Lal, M. E Ford, and U. K Braun Racial/Ethnic Disparities in Medication Use Among Veterans with Hypertension and Dementia: A National Cohort Study Ann. Pharmacother., February 1, 2009; 43(2): 185 - 193. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Kris-Etherton, J. A. Grieger, K. F. Hilpert, and S. G. West Milk Products, Dietary Patterns and Blood Pressure Management J. Am. Coll. Nutr., February 1, 2009; 28(Supplement_1): 103S - 119S. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kobori, A. B. Alper Jr, R. Shenava, A. Katsurada, T. Saito, N. Ohashi, M. Urushihara, K. Miyata, R. Satou, L. L. Hamm, et al. Urinary Angiotensinogen as a Novel Biomarker of the Intrarenal Renin-Angiotensin System Status in Hypertensive Patients Hypertension, February 1, 2009; 53(2): 344 - 350. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Williams, S. M. Brown, and P. R. Conlin Blood-Pressure Measurement N. Engl. J. Med., January 29, 2009; 360(5): e6 - e6. [PDF] |
||||
![]() |
P. de Chazal, C. Heneghan, and W. T McNicholas Multimodal detection of sleep apnoea using electrocardiogram and oximetry signals Phil Trans R Soc A, January 28, 2009; 367(1887): 369 - 389. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.R Fernandez, R.C Hermida, and A Mojon Chronobiological analysis techniques. Application to blood pressure Phil Trans R Soc A, January 28, 2009; 367(1887): 431 - 445. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. H. Messerli and S. Bangalore Antihypertensive Efficacy of Aliskiren: Is Hydrochlorothiazide an Appropriate Benchmark? Circulation, January 27, 2009; 119(3): 371 - 373. [Full Text] [PDF] |
||||
![]() |
WRITING GROUP MEMBERS, D. Lloyd-Jones, R. Adams, M. Carnethon, G. De Simone, T. B. Ferguson, K. Flegal, E. Ford, K. Furie, A. Go, et al. Heart Disease and Stroke Statistics--2009 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation, January 27, 2009; 119(3): e21 - e181. [Full Text] [PDF] |
||||
![]() |
R. E. Schmieder, T. Philipp, J. Guerediaga, M. Gorostidi, B. Smith, N. Weissbach, M. Maboudian, J. Botha, and H. van Ingen Long-Term Antihypertensive Efficacy and Safety of the Oral Direct Renin Inhibitor Aliskiren: A 12-Month Randomized, Double-Blind Comparator Trial With Hydrochlorothiazide Circulation, January 27, 2009; 119(3): 417 - 425. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. McGill Reexamining Misconceptions About {beta}-Blockers in Patients With Diabetes Clin. Diabetes, January 1, 2009; 27(1): 36 - 46. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-S. Wu, Y.-C. Yang, F.-H. Lu, C.-H. Wu, R.-H. Wang, and C.-J. Chang Population-Based Study on the Prevalence and Risk Factors of Orthostatic Hypotension in Subjects With Pre-Diabetes and Diabetes Diabetes Care, January 1, 2009; 32(1): 69 - 74. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. P. Adams Jr Secondary Prevention of Atherothrombotic Events After Ischemic Stroke Mayo Clin. Proc., January 1, 2009; 84(1): 43 - 51. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yan, K. E. North, C. M. Ballantyne, F. L. Brancati, L. E. Chambless, N. Franceschini, G. Heiss, A. Kottgen, J. S. Pankow, E. Selvin, et al. Transcription Factor 7-Like 2 (TCF7L2) Polymorphism and Context-Specific Risk of Type 2 Diabetes in African American and Caucasian Adults: The Atherosclerosis Risk in Communities Study Diabetes, January 1, 2009; 58(1): 285 - 289. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L.B. Gunther, A. D. Liese, R. A. Bell, D. Dabelea, J. M. Lawrence, B. L. Rodriguez, D. A. Standiford, and E. J. Mayer-Davis Association Between the Dietary Approaches to Hypertension Diet and Hypertension in Youth With Diabetes Mellitus Hypertension, January 1, 2009; 53(1): 6 - 12. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. F. Drager, L. A. Bortolotto, E. M. Krieger, and G. Lorenzi-Filho Additive Effects of Obstructive Sleep Apnea and Hypertension on Early Markers of Carotid Atherosclerosis Hypertension, January 1, 2009; 53(1): 64 - 69. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ninomiya, Y. Kiyohara, Y. Tokuda, Y. Doi, H. Arima, A. Harada, Y. Ohashi, H. Ueshima, and for the Japan Arteriosclerosis Longitudinal Study Impact of Kidney Disease and Blood Pressure on the Development of Cardiovascular Disease: An Overview From the Japan Arteriosclerosis Longitudinal Study Circulation, December 16, 2008; 118(25): 2694 - 2701. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bakker, S. L. Rifas-Shiman, K. P. Kleinman, S. E. Lipshultz, and M. W. Gillman Maternal Calcium Intake During Pregnancy and Blood Pressure in the Offspring at Age 3 Years: A Follow-up Analysis of the Project Viva Cohort Am. J. Epidemiol., December 15, 2008; 168(12): 1374 - 1380. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. B. Kannel and P. A. Wolf Framingham Study Insights on the Hazards of Elevated Blood Pressure JAMA, December 3, 2008; 300(21): 2545 - 2547. [Full Text] [PDF] |
||||
![]() |
R. C. Sherrick Will Running the Numbers First Violate the Principles of Patient-Centered Care? Ann Intern Med, December 2, 2008; 149(11): 839 - 840. [Full Text] [PDF] |
||||
![]() |
M.-A. Cornier, D. Dabelea, T. L. Hernandez, R. C. Lindstrom, A. J. Steig, N. R. Stob, R. E. Van Pelt, H. Wang, and R. H. Eckel The Metabolic Syndrome Endocr. Rev., December 1, 2008; 29(7): 777 - 822. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Radbill, B. Murphy, and D. LeRoith Rationale and Strategies for Early Detection and Management of Diabetic Kidney Disease Mayo Clin. Proc., December 1, 2008; 83(12): 1373 - 1381. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M Reinhart, C. I Coleman, C. Teevan, P. Vachhani, and C M. White Effects of Garlic on Blood Pressure in Patients With and Without Systolic Hypertension: A Meta-Analysis Ann. Pharmacother., December 1, 2008; 42(12): 1766 - 1771. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tada, J. Nawata, H. Wang, N. Onoue, D. Zhulanqiqige, K. Ito, K. Sugimura, Y. Fukumoto, and H. Shimokawa Enhanced pulsatile pressure accelerates vascular smooth muscle migration: implications for atherogenesis of hypertension Cardiovasc Res, December 1, 2008; 80(3): 346 - 353. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Eriksson, P.-A. Jansson, B. Carlberg, A. Hagg, L. Kurland, M. K. Svensson, H. Ahlstrom, C. Strom, L. Lonn, K. Ojbrandt, et al. Hydrochlorothiazide, but not Candesartan, Aggravates Insulin Resistance and Causes Visceral and Hepatic Fat Accumulation: The Mechanisms for the Diabetes Preventing Effect of Candesartan (MEDICA) Study Hypertension, December 1, 2008; 52(6): 1030 - 1037. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |